Terpenoid ID | TKC171689 | |
Cell line | 0 | |
Protein target | 7 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 13 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC171689 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 20596 | nM | Potency |
TKC171689 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 23778 | nM | Potency |
TKC171689 | Q99700 | Ataxin-2 | ATXN2 | 251 | nM | Potency |
TKC171689 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 35481 | nM | Potency |
TKC171689 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | PIN1 | 67456 | nM | Potency |
TKC171689 | P11308 | Transcriptional regulator ERG | ERG | 31623 | nM | Potency |
TKC171689 | Q99816 | Tumor susceptibility gene 101 protein | TSG101 | 28184 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q13526 | PIN1_HUMAN | Lung cancer [ICD-11: 2C25] |
Q13526 | PIN1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
Q99816 | TS101_HUMAN | Influenza [ICD-11: 1E30-1E32] |